Free Trial

Immunome (IMNM) SEC Filings & 10K Form

Immunome logo
$8.79 +0.25 (+2.93%)
As of 04:00 PM Eastern

Recent Immunome SEC Filings

DateFilerForm TypeView
03/28/2025
4:54 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
4:15 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
4:18 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:10 PM
Immunome (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/19/2025
3:11 PM
Immunome (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
11:35 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/04/2025
4:44 PM
Immunome Aggregator, LP (Filed by)
Immunome (Subject)
Form SCHEDULE 13D/A
02/03/2025
8:01 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
4:08 PM
Immunome (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/30/2025
8:57 PM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/30/2025
3:24 PM
Immunome (Filer)
Form 424B5
01/30/2025
3:28 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2025
3:29 PM
Immunome (Filer)
Form 424B5
01/23/2025
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/25/2024
7:35 AM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
7:41 AM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
7:33 AM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
Immunome (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
9:33 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
11/13/2024
3:06 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:57 PM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:54 AM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/29/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Immunome (Subject)
Form SC 13G
10/08/2024
3:31 PM
Immunome (Filer)
Form S-3ASR
10/07/2024
6:14 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
6:26 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
1:18 PM
Immunome (Subject)
Rosett Max (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
8:05 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
8:07 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
2:21 PM
Higgins Jack (Reporting)
Immunome (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:48 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:51 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:54 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:56 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:36 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:40 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:10 PM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/18/2024
7:52 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:54 PM
Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
M.A.G.A. is Finished – This Could be even Better (Ad)

You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).

When you see what could happen – I think you’ll be excited.
06/18/2024
7:56 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:59 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:01 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:05 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2024
8:08 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:48 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:49 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:13 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:11 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:48 AM
Immunome (Filer)
Form 424B5
05/14/2024
7:05 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:02 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMNM) was last updated on 4/30/2025 by MarketBeat.com Staff
From Our Partners